BTG Share Discussion Threads

[superbarnet] 18/5/2012 18:14

Will need something special to see a big lift on monday. Here's hoping.

[fhmktg] 18/5/2012 17:32

Ouch!!
That hurt!
Hope Monday brings a swing back up...if the Greeks don't scramble out the door over the weekend!

[doctor 69] 17/5/2012 12:21

stunning performance today

[ssords] 17/5/2012 09:55

Dr 69 - thanks. Must say today BTG a lone blue amongst a sea of red my portfolio. Can remember those long gone days now, when was the reverse for BTG.
Ssords

[doctor 69] 17/5/2012 07:32

Swords
3% net royalty

[fhmktg] 17/5/2012 00:26

That's better!

[cockneytrader] 16/5/2012 22:32

cheer up

btg have bucked the trend. they have a pipeline to go it alone, or else get taken out at a price. there are not many companies in good (great) shape. it is my believe that a tidal wave of money will hit this company soon, that money maybe friend or foe but either way it will come!

[fhmktg] 16/5/2012 17:37

BTG hold the licencing rights from the original patentees, I believe.
Roll on Monday - I need cheering up.
£190million anybody?

[ssords] 16/5/2012 16:56

Can anyone tell me what is connection BTG with Abiraterone
Ssords

[superbarnet] 16/5/2012 15:12

I am back in today as this has shown great resilience in very choppy markets

[bargainbob] 16/5/2012 12:41

The funny thing is if you can be funny with this subject :

"Earlier this year the Scottish Medicines Consortium said the cost of the drug did not justify the health benefits, but it is still in discussions with the manufactures."

Scotland has first hand evidence that the drug works the Lockerbie bomber is now 1000 days past release.

[doctor 69] 16/5/2012 07:23

excellent new d=for patients and btg

[aquila2001] 16/5/2012 02:35

BBC Health News 16.5.2012


Prostate drug abiraterone 'set for NHS use'

By James Gallagher

Health and science reporter, BBC News


Abiraterone has been shown to extend life for more than three months.

A drug for advanced prostate cancer, which can extend life by more than three months, is likely to be approved for NHS use in England and Wales.

Drugs watchdog NICE originally rejected abiraterone, which costs about £3,000 a month, for not being cost effective.

The decision prompted an angry response from patients and cancer charities.

NICE, which will make a final decision in June, changed its mind after the manufacturer offered the oral tablet at an undisclosed lower price.

'Wonderful news'

Prostate cancer is the most common cancer in men. Once it spreads it cannot be cured - about 10,000 men die every year from the cancer in the UK.

Abiraterone is one of the few treatments available to prolong life in patients with advanced prostate cancer but, in February 2012, NICE (the National Institute for Health and Clinical Excellence) said it was not cost-effective


The latest draft guidelines by NICE reverse that stance.


Chief executive Sir Andrew Dillon said he was "very pleased" with the decision.

He explained the change of heart: "During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.

"This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price; further information on which patients would benefit most and clarification on how many patients could receive the drug."

Janssen said it had gone to "significant lengths" to find a solution, although the scale of the discount has not been made public.

Owen Sharp, the head of the The Prostate Cancer Charity, said: "This announcement represents a resounding triumph for each of the thousands of men with advanced prostate cancer in England and Wales who know just how much the prospect of precious extra time with their loved ones really means.


Case Study

Louis Gifford, a physiotherapist from Falmouth, was diagnosed when he was 54.

The marathon runner was told the cancer had already spread to his pelvis and lymph glands and was inoperable.

Hormone and steroid treatments were used, but struggled to contain the cancer.

Louis started taking abiraterone in September 2011, through the Cancer Drugs Fund.

He said the drug had "really improved my quality of life".

He added: "I'm able to do all the things I enjoy.

"I feel extremely lucky, I dread to think where I'd be without it."

Louis, who is now 59, had just completed a 100-mile bicycle ride.
"We are delighted that NICE has overturned its earlier decision after reviewing the evidence. We are also pleased that the manufacturer responded to our call to deliver a further reduction in price.

Cancer Research UK helped in the early stages of development of the drug and gets royalties when it is sold.

Dr Harpal Kumar, the charity's chief executive, said: "This is wonderful news for patients with advanced prostate cancer and, in part, this U-turn is down to the public's disappointment at the initial refusal.

"People's donations have allowed Cancer Research UK to fund the discovery and early development of abiraterone - now they've also helped to ensure prostate cancer patients get access to this important treatment by making their voices heard."

He said the government needed to get "exceptional" drugs to patients sooner and called on the pharmaceutical industry to "price in a realistic way".


If NICE approves the drug in June, it will have to be offered by the NHS in England and Wales.

At the moment, NHS patients in England can access the drug through the Cancer Drugs Fund, a pot of money which pays for unapproved cancer drugs.

Earlier this year the Scottish Medicines Consortium said the cost of the drug did not justify the health benefits, but it is still in discussions with the manufactures.

The Welsh government has already made a decision to fund the drug.

Prof Johann de Bono, who led the trials of abiraterone at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, said: "I'm thrilled that this drug will now be routinely available for eligible patients on the NHS.

"Abiraterone acetate is one of only a handful of life-extending drugs for these patients and, importantly, it can also improve quality of life.

"Some of my patients have been taking abiraterone for several years through a clinical trial and are still pain free."

[gregmorg] 11/5/2012 14:31

I too would enjoy a move up as always but I question whether history has shown such a move up on the figures.To my recollection it has often been a move down immediately as nothing sensational within the interim or final statement. That then has been followed by a regrouping a week or two later, maybe as the executive team do the institutional round. Obviously it is getting very much closer for the generation of significantly higher revenues so with a bit of luck more value will soon show thru. Prefer to be in this one than Euro's but each to their own!

[moretimeforlife] 11/5/2012 10:43

Was hoping the last wave was going to carry it above 400p to position it for the next boost on 21st May but looks like we may have to wait until 21st to see it transcend 400......no worries as long term potential to deliver significant value is better and more real than it has ever been in the history of BTG.

Looking forward to an seeing it rise progressively to £7-£11 over next 19 months.

Good luck to all fellow investors.

NAI/DYOR etc

(Ade, your entry and exit timing was very good again. Well done)

[fhmktg] 10/5/2012 12:38

Providing the EU has'nt gone to hell on a handcart before then, it should be a pretty encouraging set of results - at least underpinning the current share price and perhaps re-starting the upward trend!

[superbarnet] 04/5/2012 21:45

This was a big drop and shows the price was chased too far too fast. Should stablilise prior to the results on 21/5.

[fhmktg] 04/5/2012 14:57

You could be right adejuk!

[doctor 69] 03/5/2012 19:35

Bill hunt .great o see

[broadwood] 03/5/2012 16:51

Years of patience being rewarded.

[bill hunt] 03/5/2012 16:47

Another late declared trade mopping up large numbers in percentage terms of the days trade. A regular feature.

[fhmktg] 03/5/2012 16:34

Something leaking?

[adejuk] 03/5/2012 15:35

that is a batman i see.